Cross-reaction between tyrosinase peptides and cytomegalovirus antigen by T cells from patients with Vogt-Koyanagi-Harada disease

被引：69

作者：

Sugita S. ^{[1
]}

Takase H. ^{[1
]}

Kawaguchi T. ^{[1
]}

Taguchi C. ^{[2
]}

Mochizuki M. ^{[1
]}

机构：

[1] Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University Graduate School of Medicine, Bunkyo-ku, Tokyo 113-8519

[2] Department of Ophthalmology, Kurume University School of Medicine, Kurume, Fukuoka

来源：

International Ophthalmology | 2007年 / 27卷 / 2-3期

关键词：

Autoimmune disease; Cross-reaction; Melanocyte; T cells; Virusantigens;

D O I：

10.1007/s10792-006-9020-y

中图分类号：

学科分类号：

摘要：

Aim: To determine whether T lymphocytes of patients with Vogt-Koyanagi-Harada (VKH) disease cross-react with peptides of melanocytes and with exogenous antigens. Methods: Cross-reactivity with melanocyte peptides, tyrosinase (tyrosinase450-462: SYLQDSDPDSFQD) and the mimic virus peptide, i.e., cytomegalovirus envelope glycoprotein H (CMV-egH290-302: SYLKDSDFLDAAL) was examined by a lymphocyte proliferation assay or cytokine production. The seroprevalence of various viruses was examined by a complement fixation test. To examine if the virus infections in VKH patients were latent, we measured genomic DNA of the virus using real-time polymerase chain reaction (PCR). Result: Some of the T cells established from VKH recognized melanocyte peptides including the tyrosinase peptide as well as the CMV-egH290-302 peptide, which had a high amino acid homology to the tyrosinase peptide. Cytomegalovirus (CMV) peptide-specific T cells showed a significant proliferation not only to CMV-egH290-302 but also to tyrosinase450-462. The seroprevalence of CMV was significantly higher in VKH patients. In addition, all tested samples of VKH patients were negative for CMV-DNA. Conclusions: These results indicate that CMV infection may stimulate the production of T cells that cross-react with tyrosinase by a mechanism of molecular mimicry. These events may be responsible for the onset of VKH disease. © Springer Science+Business Media, Inc. 2007.

引用

页码：87 / 95

页数：8

共 24 条

[11]

Zhao Z., Granucci S., Yeh F., Et al., Molecular mimicry by herpes simplex virus-type 1: Autoimmune disease after viral infection, Science, 279, pp. 1344-1353, (1998)

[12]

Bassili S.S., Peyman G.A., Gebhardt B.M., Et al., Detection of Epstein-Barr virus DNA by polymerase chain reaction in the vitreous from a patient with Vogt-Koyanagi-Harada syndrome, Retina, 16, pp. 160-161, (1996)

[13]

Sugita S., Takase H., Taguchi C., Et al., Ocular infiltrating CD4<sup>+</sup>T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens, Invest Ophthalmol Vis Sci, 47, pp. 2547-2554, (2006)

[14]

Read R.W., Holland G.N., Rao N.A., Et al., Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: Report of an international committee on nomenclature, Am J Ophthalmol, 131, pp. 647-652, (2001)

[15]

Rammensee H.G., Friede T., Stevanovic S., MHC ligands and peptide motifs: First listing, Immunogenetics, 41, pp. 178-228, (1995)

[16]

Hill C.M., Liu A., Marshall K.W., Et al., Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401, J Immunol, 152, pp. 2890-2898, (1994)

[17]

Shichijo S., Nakao M., Imai Y., Et al., A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes, J Exp Med, 187, pp. 277-288, (1998)

[18]

Kimura H., Morita M., Yabuta Y., Et al., Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay, J Clin Microbiol, 37, pp. 132-136, (1999)

[19]

Linhares M.I., de Andrade G.P., Tateno S., Et al., Prevalence of cytomegalovirus antibodies in Brazilian and Japanese populations in the north-east of Brazil, Microbiol Immunol, 33, pp. 975-980, (1989)

[20]

Topalian S.L., Gonzales M.I., Parkhurst M., Et al., Melanoma-specific CD4<sup>+</sup> T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes, J Exp Med, 183, pp. 1965-1970, (1996)

← 1 2 3 →